"N Engl J Med"[journal] 检索结果

281. Addressing Socioeconomic Barriers to Residency Choice.

作者: Debra F Weinstein.;Elena Olson.;John Patrick T Co.
来源: N Engl J Med. 2025年392卷14期1353-1355页

282. Ensuring Inclusive, Affirming Care for LGBTQ+ Patients - Scaling Up Cultural Competency Training.

作者: Jay M Behel.;Sally Lemke.;Sanjeev Singh.
来源: N Engl J Med. 2025年392卷14期1358-1360页

283. Breaking the Sacred Promise.

作者: Asitha Jayawardena.
来源: N Engl J Med. 2025年392卷14期1360-1361页

284. Advancing Health Equity in the Climate Crisis - A Climate Justice Curriculum for Resident Physicians.

作者: Harleen Marwah.;Mark McShane.;Paul Devine Bottone.;Noreena Sondhi Lewis.
来源: N Engl J Med. 2025年392卷14期1355-1356页

285. Developing a Primary Care Workforce for Underserved Communities - The UC Davis TEACH Program.

作者: Stephany Sanchez.;Mark C Henderson.;Heather Vierra.;Tonya L Fancher.
来源: N Engl J Med. 2025年392卷14期1357-1358页

286. Postexercise Facilitation of Reflexes in the Lambert-Eaton Myasthenic Syndrome.

作者: Barend W Florijn.;Umesh A Badrising.
来源: N Engl J Med. 2025年392卷14期e38页

287. A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis.

作者: Daniel Blockmans.;Sara K Penn.;Arathi R Setty.;Wolfgang A Schmidt.;Andrea Rubbert-Roth.;Ellen M Hauge.;Helen I Keen.;Tomonori Ishii.;Nader Khalidi.;Christian Dejaco.;Maria C Cid.;Bernhard Hellmich.;Meng Liu.;Weihan Zhao.;Ivan Lagunes.;Ana B Romero.;Peter K Wung.;Peter A Merkel.; .
来源: N Engl J Med. 2025年392卷20期2013-2024页

Giant-cell arteritis is a systemic vasculitis with limited treatment options. The efficacy and safety of upadacitinib - a selective Janus kinase (JAK) inhibitor that blocks the signaling of several cytokines, including interleukin-6 and interferon-γ - are unknown in patients with giant-cell arteritis.

288. Cervical Cancer. Reply.

作者: Krishnansu S Tewari.
来源: N Engl J Med. 2025年392卷13期1351页

289. Cervical Cancer.

作者: Casper Rokx.
来源: N Engl J Med. 2025年392卷13期1350-1351页

290. Cervical Cancer.

作者: Linda Harris.
来源: N Engl J Med. 2025年392卷13期1350页

291. Cervical Cancer.

作者: Eric J Suba.
来源: N Engl J Med. 2025年392卷13期1349-1350页

292. Clearance of Driver Mutations in Myelofibrosis. Reply.

作者: Nico Gagelmann.;Nicolaus Kröger.
来源: N Engl J Med. 2025年392卷13期1349页

293. Clearance of Driver Mutations in Myelofibrosis.

作者: Elisa Rumi.;Oscar Borsani.
来源: N Engl J Med. 2025年392卷13期1348-1349页

294. Modest Blood Pressure Increase with Age in Adults with Down's Syndrome.

作者: Andrea Kelly.;Meghan Shirley Bezerra.;Kate Fitzpatrick.;Kat Adams.;Ahtish Arputhan.;Rachel Walega.;Patricia Y Chu.;John Cockcroft.;Raymond R Townsend.
来源: N Engl J Med. 2025年392卷13期1346-1348页

295. Working at Cross-PURPOSEs to Ending HIV.

作者: Glenda E Gray.;W D Francois Venter.
来源: N Engl J Med. 2025年392卷13期1344-1345页

296. A "Hot" Cardiomyopathy.

作者: Gautam Sen.;Elizabeth Wilson.;Daniel Sado.;Rachel Bastiaenen.;Stefania Rosmini.
来源: N Engl J Med. 2025年392卷13期1335-1342页

297. Neonatal Lupus.

作者: Jing Mao.;Chao Ji.
来源: N Engl J Med. 2025年392卷13期e35页

298. Malaria.

作者: Johanna P Daily.;Sunil Parikh.
来源: N Engl J Med. 2025年392卷13期1320-1333页

299. Association between Wealth and Mortality in the United States and Europe.

作者: Sara Machado.;Ilias Kyriopoulos.;E John Orav.;Irene Papanicolas.
来源: N Engl J Med. 2025年392卷13期1310-1319页

Amid growing wealth disparity, we have little information on how health among older Americans compares with that among older Europeans across the distribution of wealth.

300. The Genetic Architecture of Congenital Diarrhea and Enteropathy.

作者: Zeenat Gaibee.;Neil Warner.;Katlynn Bugda Gwilt.;Wenjuan Li.;Rei Guan.;Michael Yourshaw.;Ryder Whittaker Hawkins.;Christiane Zorbas.;Jonathan St-Germain.;Mahdi Tabatabaie.;Suli Mao.;Vered Pinsk.;Baruch Yerushalmi.;Lee-Kai Wang.;Stanley F Nelson.;Laura Wozniak.;Dror S Shouval.;Manar Matar.;Amit Assa.;Nathaniel Frost.;Lissette Jimenez.;Sari Acra.;Thomas Walters.;Stephen Mouat.;Michael Li.;Denis L J Lafontaine.;Matthew Tyska.;Brian Raught.;Yaron Avitzur.;Wayne I Lencer.;James R Goldenring.;Martín G Martín.;Jay R Thiagarajah.;Aleixo M Muise.
来源: N Engl J Med. 2025年392卷13期1297-1309页

Next-generation sequencing has enabled precision therapeutic approaches that have improved the lives of children with rare diseases. Congenital diarrhea and enteropathies (CODEs) are associated with high morbidity and mortality. Although treatment of these disorders is largely supportive, emerging targeted therapies based on genetic diagnoses include specific diets, pharmacologic treatments, and surgical interventions.

结果排序

文献格式

出版时间

出版类型

出版语言